Cargando…
Third-Line Antiretroviral Therapy: What Do We Do When the Appropriate Formulations Are Not Available?
Children on antiretroviral therapy have limited options, particularly if they are failing therapy and live in resource-poor settings. We describe three cases where children accessed third-line antiretroviral therapy off-label, or used them extemporaneously with successful outcomes. We then review th...
Autores principales: | Frigati, Lisa Jane, Rabie, Helena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032725/ https://www.ncbi.nlm.nih.gov/pubmed/35455517 http://dx.doi.org/10.3390/children9040473 |
Ejemplares similares
-
What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008) -
Experiencing mathematics: what do we do, when we do mathematics?
por: Hersh, Reuben
Publicado: (2014) -
What Do We Want? INHIBITION. When Do We Want it? NOW
por: Maguire, Jamie L.
Publicado: (2019) -
What do we mean when we say an operation works?
por: Villar, Richard
Publicado: (2016) -
It is time to consider third-line options in antiretroviral-experienced paediatric patients?
por: van Zyl, Gert U, et al.
Publicado: (2011)